Patents by Inventor Edgar Voss

Edgar Voss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenylpyridine derivatives
    Publication number: 20070032530
    Abstract: The present invention relates to the compounds of formula I: their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing such compounds and their manufacture, as well as the use of such compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: August 1, 2006
    Publication date: February 8, 2007
    Inventors: Birgit Bossenmaier, Thomas Friess, Rolf Juchem, Lothar Kling, Irene Kolm, Hans-Willi Krell, Thomas von Hirschheydt, Edgar Voss
  • Imidazole derivatives and their use as pharmaceutical agents
    Patent number: 7169781
    Abstract: Compounds of the general formula (I) are presented which arevaluable therapeutics for the treatment of cancer and cancer related diseases.
    Type: Grant
    Filed: October 12, 2004
    Date of Patent: January 30, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Konrad Honold, Stefan Scheiblich, Thomas von Hirschheydt, Edgar Voss
  • Benzylether derivatives
    Patent number: 7163953
    Abstract: Objects of the present invention are the compounds of formula (I) their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Grant
    Filed: May 18, 2005
    Date of Patent: January 16, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Thomas Friess, Christian Geletneky, Guy Georges, Irene Kolm, Edgar Voss
  • Triarylimidazoles
    Patent number: 7144889
    Abstract: Compounds of the general formula (I) are presented and are valuable therapeutics for the treatment of cancer and cancer related diseases.
    Type: Grant
    Filed: October 6, 2004
    Date of Patent: December 5, 2006
    Assignee: Hoffman-La Roche Inc.
    Inventors: Thomas von Hirschheydt, Edgar Voss
  • Triazole derivatives
    Publication number: 20060211750
    Abstract: The present invention relates to the compounds of formula I their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, compositions containing such compounds and their manufacture, as well as the use of such compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: September 14, 2005
    Publication date: September 21, 2006
    Inventors: Walter-Gunar Friebe, Ulrike Reiff, Thomas von Hirschheydt, Edgar Voss
  • Amide derivatives
    Publication number: 20060116407
    Abstract: The present invention relates to the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: November 15, 2005
    Publication date: June 1, 2006
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Eike Hoffmann, Thomas von Hirschheydt, Edgar Voss
  • Azole derivatives
    Publication number: 20060069095
    Abstract: Compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, are disclosed. Also disclosed are methods of preparation of the above-mentioned compounds, pharmaceutical compositions and salts and esters thereof containing them, as well as the use of the above-mentioned compounds in the treatment, control or prevention of illnesses such as cancer.
    Type: Application
    Filed: September 21, 2005
    Publication date: March 30, 2006
    Inventors: Thomas Hofmeister, Ulrike Reiff, Thomas von Hirschheydt, Edgar Voss
  • Indole derivatives
    Publication number: 20060063812
    Abstract: The present invention relates to the compounds of formula I: their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, compositions containing such compounds and their manufacture, as well as the use of such compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: September 20, 2005
    Publication date: March 23, 2006
    Inventors: Thomas Friess, Ulrike Reiff, Matthias Rueth, Edgar Voss
  • Thioether derivatives
    Patent number: 7005526
    Abstract: Objects of the present invention are the compounds of formula (I) formula (I), their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.
    Type: Grant
    Filed: May 18, 2005
    Date of Patent: February 28, 2006
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Thomas Friess, Lothar Kling, Ulrike Reiff, Edgar Voss
  • Novel benzylether derivatives
    Publication number: 20050267178
    Abstract: Objects of the present invention are the compounds of formula (I) their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: May 18, 2005
    Publication date: December 1, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Thomas Friess, Christian Geletneky, Guy Georges, Irene Kolm, Edgar Voss
  • NOVEL THIOETHER DERIVATIVES
    Publication number: 20050267179
    Abstract: Objects of the present invention are the compounds of formula (I) their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: May 18, 2005
    Publication date: December 1, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Thomas Friess, Lothar Kling, Ulrike Reiff, Edgar Voss
  • Novel diazine derivatives
    Publication number: 20050222228
    Abstract: The present invention provides compounds of formula (I): their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: March 31, 2005
    Publication date: October 6, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Wolfgang Jenni, Matthias Rueth, Edgar Voss
  • Novel ether derivatives
    Publication number: 20050209290
    Abstract: The present invention provides the compounds of formula (I) their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: March 17, 2005
    Publication date: September 22, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Thomas Friess, Ulrike Reiff, Edgar Voss
  • 2-(2,6-Dichlorophenyl)-Diarylimidazoles
    Patent number: 6946471
    Abstract: This invention is directed to compounds of formula (I), which are valuable therapeutics for the treatment of cancer and cancer related diseases.
    Type: Grant
    Filed: May 18, 2004
    Date of Patent: September 20, 2005
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Brandt, Georg Fertig, Hans-Willi Krell, Thomas von Hirschheydt, Edgar Voss
  • Novel oxidized thioether derivatives
    Publication number: 20050203064
    Abstract: The present invention provides the compounds of formula I their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: March 4, 2005
    Publication date: September 15, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Thomas Friess, Lothar Kling, Matthias Rueth, Edgar Voss
  • Novel pentafluorosulfanyl compounds
    Publication number: 20050197370
    Abstract: The present invention provides the compounds of formula I-A their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: March 4, 2005
    Publication date: September 8, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Guy Georges, Matthias Rueth, Edgar Voss
  • Novel arylazole derivatives, their manufacture and use as pharmaceutical agents
    Publication number: 20050124670
    Abstract: There are presented compounds of formula (I) their pharmaceutically acceptable salts, enantiomeric forms thereof, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: October 15, 2004
    Publication date: June 9, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Ulrike Reiff, Matthias Rueth, Edgar Voss
  • Novel imidazole derivatives and their use as pharmaceutical agents
    Publication number: 20050113342
    Abstract: Compounds of the general formula (I) are presented which arevaluable therapeutics for the treatment of cancer and cancer related diseases.
    Type: Application
    Filed: October 12, 2004
    Publication date: May 26, 2005
    Inventors: Konrad Honold, Stefan Scheiblich, Thomas von Hirschheydt, Edgar Voss
  • Novel triarylimidazoles
    Publication number: 20050085473
    Abstract: Compounds of the general formula (I) are presented and are valuable therapeutics for the treatment of cancer and cancer related diseases.
    Type: Application
    Filed: October 6, 2004
    Publication date: April 21, 2005
    Inventors: Thomas van Hirschheydt, Edgar Voss
  • Novel oxazoles, their manufacture and use as pharmaceutical agents
    Publication number: 20050038091
    Abstract: The present invention relates to novel oxazoles of formula (I) their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: August 3, 2004
    Publication date: February 17, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Ulrike Reiff, Matthias Rueth, Edgar Voss